Möchten Sie immer auf dem neuesten Stand bleiben?

Splash expands its exclusive global license for CannEpil® to include veterinary applications, creating a second regulated pharmaceutical development platfo

Commercial Channel Revenue Increased 17% to a Record $13.9 Million Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020 Raising Full-Year...

SUNNYVALE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: Revenues of $678.2...

Austin, TX, USA, July 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “AI in Medical Coding Market Size, Trends and Insights By Mode (Outsourced,...

Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging  Highly sensitive...

Fremont, CA, July 28, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the...

Austin, TX, USA, July 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Digital Transformation in Healthcare Market Size, Trends and Insights By...

Austin, TX, USA, July 28, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Precision Diagnostics and Medicine Market Size, Trends and Insights By Biomarker...

New York, USA, July 28, 2026 (GLOBE NEWSWIRE) -- Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight  The...